CD9 and melanoma: The analysis of the nuclear compartment of melanoma cells pre‐treated with monovalent or divalent Abs prior to incubation with CD9‐GFP+ EVs (2.5 × 108 particle per mL) showed a decrease or an increase in the CD9‐GFP+ signals in the nucleoplasm respectively, compared to the control (Figure 3A, section, green circle; 3C; see also Table 1).